OTCMKTS:ITHUF

iAnthus Capital (ITHUF) Stock Price, News & Analysis

$0.02
0.00 (0.00%)
(As of 04/25/2024 ET)
Today's Range
$0.0165
$0.0188
50-Day Range
$0.02
$0.02
52-Week Range
$0.01
$0.04
Volume
3,200 shs
Average Volume
198,550 shs
Market Capitalization
N/A
P/E Ratio
0.12
Dividend Yield
N/A
Price Target
N/A
ITHUF stock logo

About iAnthus Capital Stock (OTCMKTS:ITHUF)

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada.

ITHUF Stock Price History

ITHUF Stock News Headlines

iAnthus Provides Update on Executive Team
Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
iAnthus Announces Resignation of Director
iAnthus Announces Extension of New Jersey Bridge Notes
iAnthus Announces Extension of New Jersey Bridge Notes
Move Your Money Before May 1
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Bengal Capital FY2023 Letter
iAnthus Reports Third Quarter 2023 Financial Results
High Capex, High Rewards: Analyst Looks At Cannabis MSOs' Strategies
iAnthus Announces Launch of Edible Brand MOODZ
iAnthus Provides Update on Executive Team
iAnthus Capital gets new CEO
8-K: iANTHUS CAPITAL HOLDINGS, INC.
Capital One 360 CD Rates: May 2023
See More Headlines
Receive ITHUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:ITHUF
Fax
N/A
Employees
717
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Richard Proud (Age 44)
    CEO & Director
    Comp: $556.73k
  • Mr. Philippe Faraut (Age 54)
    Executive Officer
    Comp: $452.92k
  • Mr. Justin Vu
    Interim Chief Financial Officer
  • Ms. Megan W. Kulick CFA
    Vice President of Investor Relations
  • Mr. Andrew R. Ryan Esq.
    General Counsel
  • Mr. Michael R. Woolston
    Senior Vice President of Manufacturing, Supply Chain & Quality

ITHUF Stock Analysis - Frequently Asked Questions

How have ITHUF shares performed in 2024?

iAnthus Capital's stock was trading at $0.0268 at the beginning of 2024. Since then, ITHUF shares have decreased by 29.9% and is now trading at $0.0188.
View the best growth stocks for 2024 here
.

Are investors shorting iAnthus Capital?

iAnthus Capital saw a decline in short interest in April. As of April 15th, there was short interest totaling 2,300 shares, a decline of 93.0% from the March 31st total of 32,700 shares. Based on an average daily trading volume, of 362,600 shares, the days-to-cover ratio is currently 0.0 days.
View iAnthus Capital's Short Interest
.

How do I buy shares of iAnthus Capital?

Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ITHUF) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners